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© 2012 The Japan Society of Histochemistry andFGF1 is highly expressed in n urons d it has been proposed to play a role in the
neuroprotection and in regeneration. Low FGF1 expression in neurons has been linked to
increased vulnerability in cholinergic neurons. Previous reports have shown that the
expression of FGF1 in rat brain is localized to the cholinergic nuclei of the medulla oblongata,
with low ratio of neurons positive for FGF1 in the dorsal motor nucleus of the vagus (DMNV).
The role of FGF1 in the primate brain has yet to be clarified. In this study, we mapped FGF1
immunoreactivity in the medulla oblongata of cynomolgus monkey brainstems. Our results
demonstrated that FGF1 immunoreactivity follows the pattern of distribution of cholinergic
nuclei in the medulla oblongata; with strong localization of FGF1 to cholinergic neurons of
the hypoglossal nucleus, the facial nucleus and the nucleus ambiguus. In contrast, the DMNV
shows markedly lower FGF1 immunoreactivity. Localization of FGF1 to cholinergic neurons
was only observed in the lateral region of the DMNV, with higher immunoreactivity in the
rostral ventral-lateral region of the DMNV. These findings are consistent with the distribution
of FGF1 immunoreactivity in previous studies of the rat brain.
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I. Introduction
Acidic fibroblast growth factor (FGF1, also abbre-
viated as aFGF or FGF-1) is a member of the fibroblast
growth factor (fgf) family. It was first discovered alongside
basic fibroblast growth factor (FGF2) by Thomas et al. [40].
FGF1 was isolated from bovine brain, and was named
for its mitogenic activity on fibroblast proliferation. In the
nervous system, it is predominantly expressed in neuronal
cells, with little to no expression in glial cells [11, 37],
and expressed particularly in subpopulations of cholinergic
neurons [9, 10]. FGF1 is secreted through a non-classical
pathway [26], and shows potent neurotrophic and neuro-
protective functions [17, 28]. Previous studies have pointed
to the importance of FGF1 in maturation, maintaining
plasticity, and long-term potentiation of neurons, indicating
further essential roles in memory and learning [27]. The
widespread expression of FGF1 throughout the neural
tissue from the early developmental stage to high levels of
expression in the adult CNS, points to essential roles in
both the development and maintenance of neuronal func-
tion [6, 11, 17, 18, 32, 36].
Studies of cholinergic neurons in senescence-
accelerated mice models demonstrated that the application
of FGF1 or a fragment analog of FGF1 prolongs the period
of latency in behavioral studies and preserves septal
cholinergic neurons [34, 41]. Amyotrophic lateral sclerosis
(ALS) is a disease characterized by progressive loss of
cholinergic motor neurons in the spinal cord. A greater loss
of FGF1 in anterior horn cholinergic motor neurons was
observed in ALS cases compared to control cases [15].
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These observations taken together suggest that FGF1 plays
an important neuroprotective and regenerative role in
cholinergic neurons.
Neurons in the dorsal motor nucleus of the vagus
(DMNV) of the medulla oblongata are more vulnerable to
injury and have a lower recovery rate when injured [2, 22].
In studies using rodents, high expression of FGF1 was
observed in cholinergic neurons in the hypoglossal nucleus,
the nucleus ambiguus, and the facial nucleus, while low
expression was observed in the lateral region of the DMNV
[23, 33]. The laryngeal nerve, which is partly innervated
by the DMNV, is notoriously slow to recover from nerve
damage for reasons that remain unclear. Interestingly,
studies in rats have shown that neurons projecting their
axons to the laryngeal nerve from the DMNV have low
levels of FGF1 expression [42]. These observations sug-
gest that low FGF1 expression may partly explain the poor
recovery of the laryngeal nerve.
While extensive studies of FGF1 have been undertaken
in rodents, information on non-human primate animal
models is not yet available. Such data would be highly
informative in determining the role of FGF1 in the survival
of cholinergic neurons. In this study, we sought to eluci-
date the distribution of FGF1 in the cranial nuclei of the
medulla oblongata of the cynomolgus monkey (Macaca
fascicularis), using immunohistochemical techniques.
II. Materials and Methods
Sample preparation
Brain stem samples were obtained from four cyno-
molgus monkeys (Macaca fascicularis), euthanized under
deep pentobarbital anaesthesia, after use for separate
research purposes by other researchers. The protocols for
the use of animals in the current study were assessed and
approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of Shiga University of Medical Science.
For immunohistochemistry, the brains were removed from
two male (5 years and 3 months old; weighing 3.38–4.68
kg) and one female (5 years old; weighing 3.28 kg) cyno-
molgus monkeys, perfused with 500 ml of saline followed
with 500 ml 4% formaldehyde in 0.1 M phosphate buffer
(PB, pH 7.4) under deep pentobarbital anaesthesia. The
brains were immediately post-fixed in 4% formaldehyde in
0.1 M PB at 4°C for 2 days. Samples were immersed in
15% sucrose in 0.1 M PB with 0.1% sodium azide, with
daily change of sucrose solution for 4 days and were then
stored in sucrose solution until processing. The samples
were cryosectioned at –20°C into 20 μm serial coronal
sections which were floated in 0.1 M phosphate buffered
saline (PBS) containing 0.3% Triton X-100 (PBST, pH 7.4)
and then maintained in PBST at 4°C.
Immunohistochemistry
Immunohistochemical analyses were performed as
described previously [23, 33, 39, 42] with slight modifica-
tions. Briefly, serial sections were washed in PBST and
immersed in 0.1 M hydrochloric acid (HCl) in Milli-Q®
water for 1 min for antigen retrieval, and then washed in
PBST. Endogenous peroxidase was quenched by incubation
in 0.5% hydrogen peroxide (H2O2) in PBST for 30 min. The
sections were then washed in PBST and blocked using 4%
normal horse serum in PBST for 1 hr. The sections were
incubated for 3 days at 4°C with goat anti-choline acetyl-
transferase (ChAT) antibody (diluted 1:500, Chemicon,
Temecula, CA, USA) or with mouse monoclonal anti-FGF1
antibody (diluted 1:500) in PBST containing 0.4% normal
horse serum. The sections were then washed in PBST and
incubated with biotinylated anti-goat IgG or anti-mouse
IgG (diluted 1:500, Vector Laboratories, Burlingame, CA,
USA) in PBST containing 0.4% normal horse serum for
2 hr at room temperature. The samples were washed in
PBST and incubated in avidin-biotin-peroxidase complex
at 1:4000 dilution for 1 hr. The peroxidase-labeled sec-
tions were developed using 0.02% 3,3-diaminebenzine-
tetra-hydrochloride (DAB) in 50 mM Tris-HCl, containing
0.07% nickel ammonium sulphate and 0.005% H2O2.
FGF1 monoclonal antibody used in this study was
raised against human recombinant FGF1 [14]. An immuno-
absorption test reported previously showed abolished
staining [33, 42]. Western blot analysis was performed in
this study to confirm the antibody specificity for FGF1.
Western blot analysis
Medulla oblongata was obtained from one female
cynomolgus monkey (10 years and 4 months old; weighing
3.17 kg) euthanized under deep pentobarbital anaesthesia,
after use for separate research purposes by other research-
ers, was used for western blot analysis, performed as
described previously [23, 33] with slight modifications.
The brainstem was homogenized in 5 volumes of ice-cold
50 mM Tris-HCl (pH 7.4) containing 0.5% Triton X-100
and protease inhibitors (Complete Mini, Roche Diagnostics,
Mannheim, Germany; 1 tablet/10 ml). The homogenate was
centrifuged at 20,600 g for 20 min at 4°C. The supernatant
was collected as a crude protein fraction. Protein concen-
tration was assayed using Tecan readers Infinite M200
(Tecan, Männedorf, Switzerland). Fifty micrograms of
the crude extracted protein, and prestained precision pro-
tein standards (BioRad, Hercules, CA, USA), were electro-
phoresed on a 5–20% sodium dodecyl sulfate-polyacryl-
amide gel under reducing conditions, and then transferred
to polyvinylidene difluoride membrane (Immobilon-P;
Millipore, Billerica, MA, USA). The membrane was in-
cubated for 1 hr with 5% skimmed milk powder in 25 mM
Tris-buffered saline (TBS, pH 7.4) at room temperature,
and further incubated overnight with the monoclonal
anti-FGF1 antibody at a dilution of 1:500 in 25 mM TBS
containing 0.5% skimmed milk powder at 4°C. The mem-
brane was then washed with 25 mM TBS containing 0.1%
Tween-20 (BioRad), followed by incubation for 1 hr with
a peroxidase-labeled anti-mouse IgG (diluted 1:20,000,
Jackson ImmunoResearch Laboratories, West Grove, PA,
USA). The peroxidase labeling was detected by chemilumi-
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nescence using the SuperSignal West Pico Chemilumines-
cent Substrate (ThermoFisher Scientific, Rockford, IL,
USA).
Mapping
Mapping of FGF-1 distribution in the medulla ob-
longata of monkey brainstem was performed as described
previously [1] using a camera lucida.
Double fluorescence immunohistochemistry
Sections were washed in PBST and immersed in 0.1
M HCl in Milli-Q® water for 1 min for antigen retrieval,
then washed in PBST. Blocking was performed by soaking
in 4% normal horse serum in PBST for 1 hr. The sections
were then incubated with a mixture of mouse monoclonal
anti-FGF1 antibody (diluted 1:500) and goat anti-ChAT
antibody (diluted 1:500, Chemicon) or rabbit anti-tyrosine
hydroxylase (TH) antibody (diluted 1:2000, Biosensis,
Australia) in PBST containing 0.4% normal horse serum for
3 days at 4°C. The sections were then washed in PBST and
incubated with a mixture of fluorescent-labeled chicken
anti-mouse IgG (diluted 1:1000, Molecular Probes, Eugene,
OR, USA) with chicken anti-goat IgG or horse anti-rabbit
IgG (diluted 1:1000, Molecular Probes) in PBST at 4°C for
4 hr. The sections were then washed three times in PBST,
once in 50 mM Tris-HCl and mounted on coated glass
slides. Fluorescence was detected using a scanning laser
confocal microscope (TE2000-E, Nikon, Japan).
Quantification of FGF-1 immunoreactivity in cholinergic 
nuclei of medulla oblongata
The number of ChAT-positive, FGF1-positive and,
double-immunopositive neurons was determined by cell
counting using rostral to caudal representative sections of
the medulla oblongata processed for double fluorescence
immunohistochemistry. Confocal microscopy was em-
ployed to capture images of fluorescent labeled neurons in
the hypoglossal nucleus, the DMNV, the nucleus ambiguus,
and the facial nucleus. The images were then processed
using Adobe®Photoshop®CS2, with adjustments only
made to levels, brightness, and contrast. A cell count of
fluorescent-labeled neurons was then performed by eye,
and the percentage colocalization of FGF1-positive to
ChAT-positive neurons relative to the total number of fluo-
rescent labeled neurons was calculated for each nucleus.
III. Results
Specificity of the FGF1 monoclonal antibody
Western blots showed that the monoclonal anti-FGF1
antibody detection of a single band with a molecular weight
of about 17 kDa (Fig. 1A). The size is consistent with the
molecular weight of a native form of FGF1 [23, 33, 37].
FGF1 immunoreactivity was observed in neuronal struc-
tures (Fig. 1B). These staining signals were not seen when
the FGF1 antibody was omitted (Fig. 1C).
Distribution of FGF1 immunoreactivity in the medulla 
oblongata of cynomolgus monkeys
FGF1 immunoreactivity was detected in neuronal
structures in the medulla oblongata, with staining of
neuronal cell bodies and neural processes but no staining
was observed in glia. The FGF1-immunoreactive neuronal
structures observed in several regions of the medulla are
shown in drawings prepared using a camera lucida
(Fig. 2A–2C). There was no difference in the distribution
pattern of FGF1 immunoreactivity among the three samples
of monkey brain examined in this study. In the medulla
oblongata, FGF1-immunoreactive neurons were observed
in the raphe magnus nucleus, the inferior olive, the hypo-
glossal nucleus, the nucleus ambiguus and the DMNV.
FGF1 immunoreactivity was also observed in scattered
neurons of the raphe magnus nucleus (Fig. 2A) and inferior
olive (Fig. 2C), whereas there was a defined distribution
pattern in the hypoglossal nucleus (Fig. 2A–C) and the
nucleus ambiguus (Fig. 2B and 2C). A densely packed
population of FGF1-positive neurons was also observed in
the facial nucleus (Fig. 2A). Figure 3 shows camera lucida
drawings of FGF1 and ChAT immunostaining at a high
magnification in the regions containing the DMNV and the
hypoglossal nucleus. In the DMNV, FGF1-positive neurons
were relatively rich in the lateral region (Fig. 3A and 3C).
Fig. 1. Antibody specificity for FGF1. A; Western blot analysis of
crude protein extract from monkey medulla oblongata using mouse
monoclonal anti-FGF1 antibody. The antibody recognized a single
band at approximately 17 kDa. B; Immunostaining for FGF1 in the
monkey medulla oblongata with mouse monoclonal anti-FGF1
antibody. C; Immunostaining using no primary antibody in the
monkey medulla oblongata showed no staining. Bar=200 μm.
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More FGF1-positive neurons were observed in the rostral
region of the DMNV (Fig. 3A), than in the caudal region
of the DMNV (Fig. 3C). ChAT-positive neurons were
similarly distributed in the nucleus in the DMNV (Fig. 3B
and 3D).
We found FGF1-immunoreactive neurons in the
DMNV (Fig. 4A, 4B, 4D, and 4E), the hypoglossal nucleus,
(Fig. 4A, 4C, 4D, and 4F), the nucleus ambiguus (Fig. 5A
and 5B) and the facial nucleus (Fig. 5C and 5D). FGF1
immunoreactivity was observed in the cell bodies in the
cytoplasm, and in the neural processes, but not in the
nucleus. Immunoreactive neurons in the DMNV varied in
distribution from the rostral to caudal region of the medulla
oblongata, and were mainly observed in the lateral portion
of the DMNV. A comparison of the FGF1 distribution in
the hypoglossal nucleus and the DMNV in the caudal and
rostral regions of the medulla oblongata is shown in Fig. 4.
We observed a few small-sized neurons (10–15 μm in
diameter) [20] that were immunoreactive for FGF1 in the
DMNV. In addition, the caudal region (Fig. 4D and 4E)
Fig. 2. Camera lucida drawing of FGF1 immuno-
reactivity in the medulla oblongata of cynomolgus
monkey brainstems, prepared from representative
coronal sections of the medulla. FGF1 immuno-
reactivity is observed in rostral to caudal regions of
the medulla in the hypoglossal nucleus (XII) (A–C),
the dorsal motor nucleus of the vagus (DMNV)
(A–C), the nucleus ambiguus (Amb) (B and C), the
facial nucleus (VII) (A), the raphe magnus nucleus
(RMg) (A), and the inferior olive (IO) (C). CC
indicates the central canal.
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showed a reduced number of FGF1-positive neurons in the
DMNV compared to the rostral region (Fig. 4A and 4B).
FGF1 immunoreactivity in the hypoglossal nucleus was
similar in both rostral (Fig. 4A and 4C) and caudal regions
(Fig. 4D and 4F) of the medulla oblongata, with medium-
sized, oval-shaped neurons (30–50 μm in diameter) that
showed clear staining of FGF1 in the cytoplasm and neural
processes.
In the nucleus ambiguus, (Fig. 5A and 5B), clear FGF1
staining was present in medium-sized neurons (25–40 μm
in diameter) [21] in the cytoplasm and neural processes. In
the facial nucleus (Fig. 5C and 5D), a large population of
medium-sized, fusiform-shaped neurons were moderately
immunoreactive for FGF1.
Double immunofluorescence for FGF1 and ChAT
The distribution pattern of FGF1-positive neurons was
similar to that observed for some cholinergic neurons. In
order to clarify the localization of FGF1 in cholinergic
neurons, double immunohistochemistry was employed.
Our results showed considerably strong colocalization of
FGF1- and ChAT-positive neurons in the hypoglossal
nucleus (Fig. 6D–6F), the nucleus ambiguus (Fig. 6G–6I),
and the facial nucleus (Fig. 6J–6L). In contrast, the DMNV
(Fig. 6A–6C) showed markedly less colocalization of
FGF1- and ChAT-positive neurons, and it was mainly in
the lateral region. Higher immunoreactivity for FGF1 was
apparent in the rostral lateral region of the DMNV.
Table 1 shows the percentage of colocalization for
FGF1 and ChAT immunoreactivity. There was a high
percentage of doubly stained neurons relative to the total of
ChAT-positive neurons in the facial nucleus (70.5%), the
nucleus ambiguus (83.9%), and the hypoglossal nucleus
(71.7%), but only a low percentage in the DMNV (16.3%).
There was also a low percentage of cholinergic neurons
among FGF1-positive neurons in the DMNV, with only
48.4% in the caudal part of the DMNV, and 34.1% in the
rostral region of the DMNV, whereas a higher percentage
of cholinergic neurons was present among FGF1-positive
neurons in the facial nucleus (87.8%), the nucleus ambiguus
(66.2%), and the hypoglossal nucleus (65.5%).
Dopaminergic and noradrenergic neurons have previ-
ously been localized in the rostral region of the DMNV [3,
24]. We observed TH immunoreactivity in the DMNV
(Fig. 7A); however, FGF1 immunoreactivity in the DMNV
did not colocalize with TH-positive neurons (Fig. 7C).
Fig. 3. Camera lucida drawing of FGF1 (A and C) and ChAT (B and D) immunoreactivity in the rostral (A and B) and caudal (C and D) regions
of the dorsal motor nucleus of vagus (DMNV) and the hypoglossal nucleus (XII). CC indicates the central canal.
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Fig. 4
Fig. 5
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Fig. 6. Double immunofluorescent staining for FGF1 (green) and ChAT (red) showing colocalization of FGF1-positive and ChAT-positive
neurons in the dorsal motor nucleus of the vagus (A–C), the hypoglossal nucleus (D–F), the nucleus ambiguus (G–I), and the facial nucleus
(J–L). Few neurons in the DMNV showed colocalization (indicated by arrows) of FGF1 immunoreactivity to ChAT (A–C). Almost all of the
ChAT-positive neurons in the hypoglossal nucleus (D–F), nucleus ambiguus (G–I) and facial nucleus (J–L) were colocalized with FGF1
immunoreactivity. Bar=100 μm.
Fig. 4. Immunohistochemical staining for FGF1 in the medulla oblongata is observed in the dorsal motor nucleus of the vagus and the hypo-
glossal nucleus in rostral and caudal sections of the medulla. Strong FGF1 immunoreactivity is observed in the neurons of the hypoglossal
nucleus in both rostral and caudal areas (A, D). Higher magnification of areas in boxes (C and F) show that neural bodies and neural projections
are positive for FGF1 in the hypoglossal nucleus. The dorsal motor nucleus of the vagus shows FGF1 immunoreactivity only in the lateral
area (A) of the rostral area of medulla, and only weakly stained fibers in the caudal region (D). Higher magnification of the dorsal motor
nucleus of the vagus shows few FGF1-positive neural bodies in the rostral area (B) and in the caudal area (E). Bar=300 μm (A and D); 50 μm
(B, C, E); 100 μm (F).
Fig. 5. FGF1 immunoreactivity in the facial nucleus (A and B) and the nucleus ambiguus (C and D). At high magnification (B and D), both
neural bodies and neural processes are stained for FGF1 in the nucleus ambiguus (B) and the facial nucleus (D). Bar=100 μm.
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IV. Discussion
In the current study, we successfully mapped the
distribution of FGF1 in the medulla oblongata of Macaca
fascicularis. We demonstrated that FGF1 immunoreactivity
was restricted to neuronal structures, where it was observed
in the cytoplasm of the somata and neuronal processes, with
no immunoreactivity observed in glial cells. These results
are in good agreement with previous studies in normal rat
brains [10, 37]. A recent study by Hiruma et al. [13]
reported that neurotrophin NT-3 is colocalized with FGF1
in lung alveolar macrophages. Although we did not observe
FGF1-positive macrophage/microglia in the medulla of the
normal monkey brain, FGF1 expression may be induced in
microglia under a pathological condition.
FGF1 immunoreactivity was found extensively in
ChAT-positive neurons in the hypoglossal nucleus, the
nucleus ambiguus, the facial nucleus, and in scattered
neurons in the raphe magnus nucleus and inferior olive. The
FGF1 stained neurons ranged in size from small to medium
and in shape from fusiform to oval and ovoid-like structure.
FGF1 immunoreactivity was also observed in the inferior
olive and in axons extending from the hypoglossal nucleus.
Low immunoreactivity was observed in the DMNV, with
only a few FGF1-positive neurons found in the caudal-
lateral and rostral ventral-lateral regions. These observa-
tions are in agreement with previous studies in the rat,
where there is strong expression of FGF1 in motor neurons
of the hypoglossal nucleus and nucleus ambiguus [37].
Furthermore, FGF1-positive cells were observed previously
in the DMNV of the rat, localized predominantly in the
lateral region of the DMNV [23, 33].
FGF1 expression has been linked in various studies
to neuroprotection, rescue after injury and regeneration of
nerve tissue. The application of exogenous FGF1 rescued
neurons after ischemic injury [6], and promoted the re-
generation of sensory axons after severing of adult dorsal
roots [17]. In addition, subcutaneous injection of FGF1
was shown to delay senescence and preserve cholinergic
neurons in the medial septum of senescence-accelerated
mice [41].
The present study showed that abundant FGF1 expres-
sion in motor nuclei such as the facial nucleus, the am-
biguus nucleus, and the hypoglossal nucleus, although,
the function of such high expression of FGF1 in motor
nuclei remains unclear. Previous studies have demonstrated
Table 1. Percentage of neurons stained for ChAT and FGF1 relative to the total ChAT-positive neurons (upper row) and total FGF1-positive
neurons (lower row) in cranial nuclei in the medulla oblongata of cynomolgus monkey brainstem
Region
Facial 
nucleus
Nucleus 
ambiguus
Hypoglossal 
nucleus
DMNV 
(Total)
DMNV 
(Rostral)
DMNV 
(Caudal)
Percentage of double-positive neurons to 
total cholinergic neurons
70.5% 83.9% 71.7% 16.3% 20.1% 11.9%
Percentage of double-positive neurons to 
total FGF1-positive neurons
87.8% 66.2% 65.5% 37.9% 34.1% 48.4%
Fig. 7. Double immunofluorescent staining for FGF1 (green) (A) and TH (red) (B) in the rostral portion of the dorsal motor nucleus of the vagus.
No colocalization of FGF1-positive neurons (indicated by arrow) to TH-positive neurons (indicated by arrowheads) was observed in the DMNV
(C). Bar=200 μm.
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that FGF1 may play an important role in motor neurons.
Motor neurons possess Ca2+ permeable AMPA receptor
(AMPAR) lacking the GluR2 subunit and are selectively
vulnerable to AMPAR-mediated glutamate excitotoxicity
[4, 7, 43]. However, FGF1 interactions with FGF1R protect
neurons from glutamate excitotoxicity via GSK3β inacti-
vation by the PI3K-Akt involved pathway [12], implying
a neuroprotective function for FGF1 against glutamate
excitotoxicity in motor neurons. Previous studies have
shown that glutamate excitotoxicity is involved in motor
neuron death in ALS [25, 29, 30, 35], and motor neuron
degeneration can be triggered by induced glutamate trans-
port defect [31]. Low FGF1 expression has also been shown
in anterior horn in ALS [15]. Together, these data suggest
that the low levels of FGF1 in motor neurons play a role in
motor neuron death in ALS, and it could be postulated that
FGF1 expression correlates to the differential resistance
to injury seen in cholinergic neurons in motor nuclei.
Cholinergic neurons of the DMNV are more vulner-
able to nerve damage and notoriously difficult to recover
after injury, compared to neurons of other motor cranial
nerves [2]. In a study in rats by Navaratnam et al. [22],
marked neuronal loss with very limited recovery of neurons
in the DMNV was observed after axonal crush of the vagus
nerve. This vulnerability of neurons in the DMNV could be
linked to the low number of cells positive for FGF1, which
we observed in this study.
The DMNV shows a distinct functional somatotopic
distribution from the rostral to the caudal region [5, 8, 16,
19]. The caudal lateral region of the DMNV innervates
the trachea and esophagus, while inhibitory cardiovascular
efferents extend from the mid to rostral lateral region of the
DMNV [8]. Innervations of the subdiaphragmatic viscera
extend bilaterally from the rostral to the caudal region of
the DMNV, with efferents projecting to the stomach, intes-
tines and pancreas [16, 19, 24]. We observed limited
colocalization of FGF1 to cholinergic neurons in the lateral
region of the DMNV in this study. In addition, we observed
non-cholinergic FGF1-immunoreactive neurons, with 28%
of FGF1-positive neurons not colocalized with ChAT-
positive neurons in the rostral region. Previous studies have
reported that the rostral region of the DMNV also contains
noradrenergic and dopaminergic neurons [24, 38], although
our immunohistochemical analysis revealed no colocaliza-
tion of FGF1-positive neurons with TH-immunoreactive
neurons in the DMNV.
Our results demonstrated that the pattern of distribu-
tion and localization of FGF1 immunoreactivity in the
medulla oblongata of the cynomolgus monkey are similar
to those reported in rodents. This suggests that FGF1
may have similar function in neuroprotection and neuro-
regeneration to that observed in the DMNV of non-primate
animal models.
V. Conclusion
This study has successfully mapped the distribution
of FGF1 immunoreactivity in the medulla oblongata of
the cynomolgus monkey. Our results demonstrate that (1)
FGF1 colocalized to cholinergic neurons of cranial nuclei
in the medulla; (2) The DMNV has markedly lower FGF1
immunoreactivity compared to the hypoglossal nucleus, the
facial nucleus, and the nucleus ambiguus; and, (3) FGF1
immunoreactivity is observed only in the lateral region of
the DMNV. These observations are in good agreement with
previous studies and suggest a potentially similar function
for FGF1 in cranial nerve neurons to that seen in rodent
models.
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